Announcement

Collapse
No announcement yet.

USA: Outbreak of Lung Illness Associated with Using E-cigarette Products - 2,668 hospitalized cases, 60 fatalities

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • #46
    Health Officials Urge No Vaping After 4th Death Reported in California; 161 Hospitalized
    POSTED 3:58 PM, NOVEMBER 13, 2019, BY ASSOCIATED PRESS


    California public health officials are urging people to stop vaping and using e-cigarettes as a fourth death related to vaping was reported in the state.

    The state’s Department of Public Health said Wednesday 161 people have been hospitalized for severe breathing problems and lung damage since August.

    Marin County’s Department of Health and Human Services confirmed Wednesday the death of a previously healthy woman in her 40s who had started vaping six months ago.
    ...
    California public health officials are urging people to stop vaping and using e-cigarettes as a fourth death related to vaping was reported in the state. The state’s Department of Public Health sai…


    Michigan teen becomes first in US to have double lung transplant due to vaping damage
    BY JUSTIN WISE - 11/12/19 08:50 PM EST 165

    A Michigan teenager is reportedly believed to be the first person ever to receive a double lung transplant due to a vaping-related illness that has swept through the United States.

    "This is an evil that I haven't faced before," Dr. Hassan Nemeh, a thoracic specialist at Henry Ford Health System in Detroit, said at a news conference on Tuesday, according to NBC News.


    Doctors did not comment on whether the the 17-year-old boy had been using vaping products before becoming ill. But they stressed that individuals should stop using the products.
    ...

    Twitter: @RonanKelly13
    The views expressed are mine alone and do not represent the views of my employer or any other person or organization.

    Comment


    • #47
      Latest Outbreak Information

      Updated every Thursday
      • This complex investigation spans almost all states, involves over 2,000 patients, and a wide variety of brands and substances and e-cigarette, or vaping, products.
      • As of November 13, 2019, 2,172* cases of e-cigarette, or vaping, product use associated lung injury (EVALI) have been reported to CDC from 49 states (all except Alaska), the District of Columbia, and 2 U.S. territories (Puerto Rico and U.S. Virgin Islands).
        • Forty-two deaths have been confirmed in 24 states and the District of Columbia (as of November 13, 2019).
          • The median age of deceased patients was 52 years and ranged from 17 to 75 years (as of November 13, 2019).
        • More deaths are under investigation.
      • Among 1,378 patients with data on sex (as of October 15, 2019):
        • 70% of patients are male.
      • Among 1,364 patients with data on age (as of October 15, 2019):
        • The median age of patients is 24 years and ages range from 13 to 75 years.
        • 79% of patients are under 35 years old.
        • By age group category:
          • 14% of patients are under 18 years old;
          • 40% of patients are 18 to 24 years old;
          • 25% of patients are 25 to 34 years old; and
          • 21% of patients are 35 years or older.
      • Among 867 patients with information on substances used in e-cigarette, or vaping, products in the 3 months prior to symptom onset** (as of October 15, 2019):
        • About 86% reported using THC-containing products; 34% reported exclusive use of THC-containing products.
        • About 64% reported using nicotine-containing products; 11% reported exclusive use of nicotine-containing products.
        • ...
      https://www.cdc.gov/tobacco/basic_in...ak-information
      Twitter: @RonanKelly13
      The views expressed are mine alone and do not represent the views of my employer or any other person or organization.

      Comment


      • #48
        Indiana reports fourth vaping related death
        Posted: 2:11 PM, Nov 14, 2019 Updated: 5:09 PM, Nov 14, 2019
        By: Katie Cox

        INDIANAPOLIS — The Indiana State Department of Health is reporting a fourth person has died from severe lung injuries caused by e-cigarette use.

        Three vaping-related deaths had already been reported in the state, the first one on Sept. 6. Those three were all adults. The health department said the fourth victim was a person between the ages of 50 and 59.

        So far in Indiana there have been 57 probable cases of vaping-related lung illness and 55 confirmed cases.
        ...
        https://www.theindychannel.com/news/...-related-death

        4th Illinois resident dies of vaping-related lung injury, health officials say

        U.S. health officials are investigating what might be causing hundreds of serious breathing illnesses in people who use e-cigarettes and other vaping devices.

        Sun-Times Media Wire
        Updated 2 hours ago
        A fourth Illinois resident has died from vaping-related lung damage amid a surge in e-cigarette smoking illnesses.

        The Illinois Department of Public Health confirmed the death on Thursday, but declined to give details, citing patient privacy.

        The fatality comes less than three months since Illinois logged the first vaping death in the country on Aug. 23.

        ...
        https://abc7chicago.com/health/4th-illinois-resident-dies-of-vaping-related-lung-injury/5697586/
        Twitter: @RonanKelly13
        The views expressed are mine alone and do not represent the views of my employer or any other person or organization.

        Comment


        • #49
          Missouri reports second death related to vaping

          By Edited news release from the Missouri Department Of Health And Senior Services | Posted: Thu 8:40 PM, Nov 14, 2019

          JEFFERSON CITY, Mo. - A second person in Missouri has died from a vaping-related illness. The Missouri Department of Health and Senior Services says a woman in her mid-50s died this week.

          The agency , in discussion with the woman's treating physicians, concluded that vaping was a contributing factor to the female’s death who was experiencing a long-standing underlying chronic lung condition.
          ...
          Missouri has seen 35 confirmed or suspected cases of lung injuries related to e-cigarettes since August
          Twitter: @RonanKelly13
          The views expressed are mine alone and do not represent the views of my employer or any other person or organization.

          Comment


          • #50
            Louisiana sees first vaping death, one of more than 40 nationwide
            BY SAM KARLIN | STAFF WRITER PUBLISHED NOV 18, 2019 AT 12:34 PM | UPDATED NOV 18, 2019 AT 4:58 PM

            Louisiana has its first confirmed death from a vaping illness that has swept across the country in recent months, one of more than 40 deaths reported nationwide as officials continue to investigate the causes.

            The state now has at least 30 confirmed cases of vaping-associated lung injury, or EVALI, and the Louisiana Department of Health reported the illness is mainly associated with users vaping a combination of nicotine and THC, the ingredient in marijuana that gets users high.

            Officials offered few details about the death, including what substance the patient vaped, citing privacy concerns.
            ...
            Louisiana has its first confirmed death from a vaping illness that has swept across the country in recent months, one of more than 40 deaths reported nationwide as officials continue
            Twitter: @RonanKelly13
            The views expressed are mine alone and do not represent the views of my employer or any other person or organization.

            Comment


            • #51
              Amanda Hall can't walk. She can't even stand. Her voice is a bit shaky at times and she relies on oxygen tubes. Her doctors say vaping is to blame and it nearly cost Hall her life.

              My lungs were shutting down:' Franklinton woman warns of vaping dangers

              By Elaina Athans

              Monday, November 18, 2019 6:25PM
              DURHAM, N.C. (WTVD)
              ...
              She had been vaping less than four years, after quitting smoking, and was using nicotine.

              "I just used the regular (products) that you get from a high-quality vape store," she said. "(Doctors at first) assumed that I was doing THC or buying on Black Market or whatever, but I used the same thing about the entire time."

              She's hoping to spare others from the misery and says the situation could have been avoided.

              "To the people who think 'Oh, it can't happen to me,' it can and it will," Hall said. "I regret picking up that pen. I regret it, but if my story will help somebody else then maybe that's what this is all for and I'm OK with that."...
              _____________________________________________

              Ask Congress to Investigate COVID Origins and Government Response to Pandemic.

              i love myself. the quietest. simplest. most powerful. revolution ever. ---- nayyirah waheed

              "...there’s an obvious contest that’s happening between different sectors of the colonial ruling class in this country. And they would, if they could, lump us into their beef, their struggle." ---- Omali Yeshitela, African People’s Socialist Party

              (My posts are not intended as advice or professional assessments of any kind.)
              Never forget Excalibur.

              Comment


              • #52
                NY Health Department confirms 2nd vaping-related death
                LOCAL NEWS
                Posted: Nov 20, 2019 / 01:56 PM EST / Updated: Nov 20, 2019 / 01:57 PM EST


                ALBANY, N.Y. (AP) — New York’s Department of Health has declared the state’s second death linked to a vaping-associated illness.

                Democratic Gov. Andrew Cuomo said on Wednesday that the person who died was a man in his 30′s from Manhattan with a reported history of using e-cigarettes and vapor products.
                ...
                https://www.localsyr.com/news/local-...related-death/


                Orange County Dad: "My Son Died Because He Thought Vaping Was Safe"
                By Eric Mock Orange County
                PUBLISHED 5:55 PM EST Nov. 19, 2019 UPDATED 7:22 AM ET Nov. 20, 2019
                SHARE

                ORANGE COUNTY, Fla. — The parents of a 28-year-old man who are convinced that vaping killed their son want to warn others about the dangers of using the drug.

                Kyle Boyd died Friday, several days after being found in his room
                His father, Donald, says Boyd vaped heavily after recent divorce
                Family is convinced vaping diminished lung capacity, killed him

                ...


                Twitter: @RonanKelly13
                The views expressed are mine alone and do not represent the views of my employer or any other person or organization.

                Comment


                • #53
                  What We Know

                  New Laboratory Findings:
                  • Analyses of bronchoalveolar lavage (BAL) fluid samples (fluid samples collected from the lungs) of patients with e-cigarette, or vaping, product use associated lung injury (EVALI) identified vitamin E acetate, an additive in some THC-containing e-cigarette, or vaping, products.
                  • Recent CDC laboratory test results of BAL fluid samples from 29 patients submitted to CDC from 10 states found vitamin E acetate in all of the samples.
                    • THC was identified in 82% of the samples and nicotine was identified in 62% of the samples.
                    • CDC tested for a range of other chemicals that might be found in e-cigarette, or vaping, products, including plant oils, petroleum distillates like mineral oil, MCT oil, and terpenes (which are compounds found in or added to THC products). None of these chemicals of concern were detected in the BAL fluid samples tested.
                  • This is the first time that we have detected a chemical of concern in biologic samples from patients with these lung injuries. These findings provide direct evidence of vitamin E acetate at the primary site of injury within the lungs.
                  • These findings complement the ongoing work of FDAexternal icon and some state public health laboratories to characterize e-liquid exposures and inform the ongoing multistate outbreak.

                  About the Outbreak:
                  • As of November 20, 2019, 2,290* cases of e-cigarette, or vaping, product use associated lung injury (EVALI) have been reported to CDC from 49 states (all except Alaska), the District of Columbia, and 2 U.S. territories (Puerto Rico and U.S. Virgin Islands).
                    • Forty-seven deaths have been confirmed in 25 states and the District of Columbia (as of November 20, 2019).
                    • CDC will still collect data the week of November 24 – 30, 2019; however, updates to the latest outbreak information including case counts and death will not be available until December 5, 2019 due to the Thanksgiving holiday.
                    • Latest outbreak information is updated every Thursday.
                    • CDC continues to work closely with FDA, states, public health partners, and clinicians on this investigation.

                  About Patient Exposure:
                  • All EVALI patients have reported a history of using e-cigarette, or vaping, products.
                    • Vitamin E acetate has been identified as a chemical of concern among people with e-cigarette, or vaping, product use associated lung injury (EVALI).
                    • THC is present in most of the samples tested by FDA to date, and most patients report a history of using THC-containing e-cigarette, or vaping, products.
                    • The latest national and state findings suggest THC-containing e-cigarette, or vaping, products, particularly from informal sources like friends, or family, or in-person or online dealers, are linked to most of the cases and play a major role in the outbreak.

                  * The increase in lung injury cases from last week represents both new patients and recent reporting of previously-identified patients to CDC.

                  ...


                  Latest Outbreak Information

                  CDC will still collect data the week of November 24 – 30, 2019; however, updates to the latest outbreak information including case counts and deaths will not be available until December 5, 2019, due to the Thanksgiving holiday.
                  • This complex investigation spans almost all states, involves over 2,000 patients, and a wide variety of brands and substances and e-cigarette, or vaping, products.
                  • As of November 20, 2019, 2,290* cases of e-cigarette, or vaping, product use associated lung injury (EVALI) have been reported to CDC from 49 states (all except Alaska), the District of Columbia, and 2 U.S. territories (Puerto Rico and U.S. Virgin Islands).
                  • Forty-seven deaths have been confirmed in 25 states and the District of Columbia (as of November 20, 2019):
                    • Alabama, California (4), Connecticut, Delaware, District of Columbia, Florida, Georgia (3), Illinois (5), Indiana (4), Kansas (2), Louisiana, Massachusetts (3), Michigan, Minnesota (3), Mississippi, Missouri (2), Montana, Nebraska, New Jersey, New York (2), Oregon (2), Pennsylvania, Tennessee (2), Texas, Utah, and Virginia
                    • The median age of deceased patients was 53 years and ranged from 17 to 75 years (as of November 20, 2019).
                    • More deaths are under investigation.
                  • Among the 2,016 cases of e-cigarette, or vaping, product use associated lung injury (EVALI) reported to CDC with available data on hospitalization status (as of November 5, 2019):
                    • 95% were hospitalized, and 5% were not hospitalized.
                    • 68% were male (among 1,905 patients with data on sex)
                    • 77% were under 35 years old, with a median age of 24 years and age range from 13 to 78 years (among 1,906 patients with data on age)
                    • By age group category:
                      • 15% of patients were under 18 years old;
                      • 38% of patients were 18 to 24 years old;
                      • 24% of patients were 25 to 34 years old; and
                      • 23% of patients were 35 years or older.
                  • 1,184 patients had complete information** on substances used in e-cigarette, or vaping, products in the 3 months prior to symptom onset, of whom (as of November 5, 2019):
                    • 83% reported using THC-containing products; 35% reported exclusive use of THC-containing products.
                    • 61% reported using nicotine-containing products; 13% reported exclusive use of nicotine-containing products.
                    • 48% reported both THC- and nicotine-containing product use.
                    • 4% reported no THC- or nicotine-containing product use.

                  * The increase in lung injury cases from last week represents both new patients and recent reporting of previously-identified patients to CDC.

                  ** Based on complete reports received.
                  https://www.cdc.gov/tobacco/basic_in...ak-information
                  Twitter: @RonanKelly13
                  The views expressed are mine alone and do not represent the views of my employer or any other person or organization.

                  Comment


                  • #54
                    Louisiana reports second vaping-related death

                    WDSUUpdated: 12:44 PM CST Nov 22, 2019
                    WDSU Digital Team

                    BATON ROUGE, La. —
                    The Louisiana Department of Health announced that the state has reported its second vaping-related death.

                    The second death was reported on Friday. The first was reported on Monday.

                    According to the Department of Health, the deaths were linked to a vaping-associated lung injury, but privacy laws prevent the department from releasing any further information about the people who died.

                    The outbreak in Louisiana now includes 32 cases, according to the Department of Health's website.

                    ...
                    The Louisiana Department of Health announces that the state has reported its second vaping-related death.
                    Twitter: @RonanKelly13
                    The views expressed are mine alone and do not represent the views of my employer or any other person or organization.

                    Comment


                    • #55

                      Toxic metal, leached from e-cigarette coil, permanently scars woman's lung

                      The illness is usually only seen in industrial metal workers.


                      Dec. 5, 2019, 12:43 AM UTC
                      By Erika Edwards

                      ...
                      But when pathologists took a close look at the woman's lung tissue, it didn't look like a typical case of EVALI, or e-cigarette, or vaping, product use associated lung injury. Instead, they saw damaged cells that had engulfed other lung cells, creating giant cells — a pattern that's typically found in an illness called hard-metal lung disease....

                      _____________________________________________

                      Ask Congress to Investigate COVID Origins and Government Response to Pandemic.

                      i love myself. the quietest. simplest. most powerful. revolution ever. ---- nayyirah waheed

                      "...there’s an obvious contest that’s happening between different sectors of the colonial ruling class in this country. And they would, if they could, lump us into their beef, their struggle." ---- Omali Yeshitela, African People’s Socialist Party

                      (My posts are not intended as advice or professional assessments of any kind.)
                      Never forget Excalibur.

                      Comment


                      • #56
                        Outbreak of Lung Injury Associated with the Use of E-Cigarette, or Vaping, Products

                        Espa?ol (Spanish)

                        CDC, the U.S. Food and Drug Administration (FDA), state and local health departments, and other clinical and public health partners are investigating a national outbreak of e-cigarette, or vaping, product use associated lung injury (EVALI).

                        For the Public
                        For Healthcare Providers
                        For Health Departments
                        Resources
                        Digital Press Kit
                        On This Page
                        calendar alt icon Updated December 5, 2019, at 1:00 PM EST


                        What is New

                        CDC has identified vitamin E acetate as a chemical of concern among people with e-cigarette, or vaping, product use associated lung injury (EVALI). Recent CDC laboratory testing of bronchoalveolar lavage (BAL) fluid samples (fluid samples collected from the lungs) from 29 patients with EVALI submitted to CDC from 10 states found vitamin E acetate in all of the samples. Vitamin E acetate is used as an additive, most notably as a thickening agent in THC-containing e-cigarette, or vaping, products.

                        CDC recommends that people should not use THC-containing e-cigarette, or vaping, products, particularly from informal sources like friends, or family, or in-person or online dealers. In addition, people should not add any substance to e-cigarette or vaping products that are not intended by the manufacturer, including products purchased through retail establishments.

                        While this investigation is ongoing, vitamin E acetate should not be added to e-cigarette, or vaping, products. CDC will continue to update guidance, as appropriate, as new data become available from this complex outbreak.


                        What We Know

                        New Laboratory Findings:
                        • Analyses of bronchoalveolar lavage (BAL) fluid samples (fluid samples collected from the lungs) of patients with e-cigarette, or vaping, product use associated lung injury (EVALI) identified vitamin E acetate, an additive in some THC-containing e-cigarette, or vaping, products.
                        • Recent CDC laboratory test results of BAL fluid samples from 29 patients submitted to CDC from 10 states found vitamin E acetate in all of the samples.
                          • THC was identified in 82% of the samples and nicotine was identified in 62% of the samples.
                          • CDC tested for a range of other chemicals that might be found in e-cigarette, or vaping, products, including plant oils, petroleum distillates like mineral oil, MCT oil, and terpenes (which are compounds found in or added to THC products). None of these chemicals of concern were detected in the BAL fluid samples tested.
                        • This is the first time that we have detected a chemical of concern in biologic samples from patients with these lung injuries. These findings provide direct evidence of vitamin E acetate at the primary site of injury within the lungs.
                        • These findings complement the ongoing work of FDAexternal icon and some state public health laboratories to characterize e-liquid exposures and inform the ongoing national outbreak.

                        About the Outbreak:
                        • The EVALI cases and EVALI deaths reported as of December 4, 2019, include data from a two-week period, November 17th to November 30th.
                        • As of December 4, 2019, 2,291* cases of hospitalized e-cigarette, or vaping, product use associated lung injury (EVALI) have been reported to CDC from 50 states, the District of Columbia, and 2 U.S. territories (Puerto Rico and U.S. Virgin Islands).
                          • Forty-eight deaths have been confirmed in 25 states and the District of Columbia (as of December 4, 2019).
                        • As of December 4, 2019, CDC will only report hospitalized EVALI cases and EVALI deaths regardless of hospitalization status. CDC has removed* nonhospitalized cases from previously reported cases counts. See Public Health Reporting for more information.
                        • CDC continues to work closely with FDA, states, public health partners, and clinicians on this investigation.

                        About Patient Exposure:
                        • All EVALI patients have reported a history of using e-cigarette, or vaping, products.
                          • Vitamin E acetate has been identified as a chemical of concern among people with e-cigarette, or vaping, product use associated lung injury (EVALI).
                          • THC is present in most of the samples tested by FDA to date, and most patients report a history of using THC-containing e-cigarette, or vaping, products.
                          • The latest national and state findings suggest THC-containing e-cigarette, or vaping, products, particularly from informal sources like friends, or family, or in-person or online dealers, are linked to most of the cases and play a major role in the outbreak.

                        * Due to only reporting hospitalized EVALI cases as of December 4, 2019, CDC removed 175 nonhospitalized cases from previously reported national case counts.


                        What We Don't Know
                        • While it appears that vitamin E acetate is associated with EVALI, evidence is not yet sufficient to rule out contribution of other chemicals of concern.
                          • Many different substances and product sources are still under investigation, and it may be that there is more than one cause of this outbreak.


                        What CDC Recommends
                        • CDC recommends that people do not use THC-containing e-cigarette, or vaping, products.
                        • CDC also recommends that people should not:
                          • Buy any type of e-cigarette, or vaping, products, particularly those containing THC from informal sources like friends, or family, or in-person or online dealers.
                          • Modify or add any substances to e-cigarette, or vaping, products that are not intended by the manufacturer, including products purchased through retail establishments.
                        • While it appears that vitamin E acetate is associated with EVALI, evidence is not yet sufficient to rule out contribution of other chemicals of concern.
                          • Many different substances and product sources are still under investigation, and it may be that there is more than one cause of this outbreak.
                        • The only way to assure that you are not at risk while the investigation continues is to consider refraining from use of all e-cigarette, or vaping, products.
                        • Adults using e-cigarettes to quit smoking should not go back to smoking; they should weigh all risks and benefits and consider utilizing FDA approved cessation medicationsexternal icon. Contact your healthcare provider if you need help quitting tobacco products, including e-cigarettes.
                        • Adults who continue to use an e-cigarette, or vaping, product, should carefully monitor themselves for symptoms and see a healthcare provider immediately if they develop symptoms like those reported in this outbreak.
                        • Adults with ongoing problematic marijuana use should seek out evidence-based behavioral treatment. As appropriate, they should also seek treatment for any other co-occurring substance misuse or abuse problems or related health conditions.
                        • Regardless of the ongoing investigation:
                          • E-cigarette, or vaping, products should never be used by youths, young adults, or women who are pregnant.
                          • Adults who do not currently use tobacco products should not start using e-cigarette, or vaping, products. There is no safe tobacco product. All tobacco products, including e-cigarettes, carry a risk.
                          • THC use has been associated with a wide range of health effects, particularly with prolonged frequent use. The best way to avoid potentially harmful effects is to not use THC-containing e-cigarette, or vaping, products. Persons with ongoing problematic marijuana use that causes significant impairment or distress should seek evidence-based treatment by a health care provider.
                        • People who have significant impairment or distress from ongoing problematic use of THC-containing e-cigarette, or vaping, products should seek evidence-based behavioral treatment and recovery services.

                        Top of Page

                        Key Facts about Use of E-Cigarette, or Vaping, Products
                        • Electronic cigarettes — or e-cigarettes — are also called vapes, e-hookahs, vape pens, tank systems, mods, and electronic nicotine delivery systems (ENDS).
                        • Using an e-cigarette is commonly called vaping.
                        • E-cigarettes work by heating a liquid to produce an aerosol that users inhale into their lungs.
                        • The liquid can contain: nicotine, tetrahydrocannabinol (THC) and cannabinoid (CBD) oils, and other substances and additives. THC is the psychoactive mind-altering compound of marijuana that produces the “high”.


                        Key Facts about Vitamin E Acetate
                        • Vitamin E acetate is used as an additive, most notably as a thickening agent in THC-containing e-cigarette, or vaping, products.
                        • Vitamin E is a vitamin found in many foods, including vegetable oils, cereals, meat, fruits, and vegetables. It is also available as a dietary supplement and in many cosmetic products, like skin creams.
                        • Vitamin E acetate usually does not cause harm when ingested as a vitamin supplement or applied to the skin. However, previous research suggests when vitamin E acetate is inhaled, it may interfere with normal lung functioning.

                        If you have questions about CDC’s investigation into the lung injuries associated with use of e-cigarette, or vaping, products, contact CDC-INFO or call 1-800-232-4636.


                        Latest Outbreak Information
                        • This complex investigation spans almost all states, involves over 2,000 patients, and a wide variety of brands and substances and e-cigarette, or vaping, products.
                        • As of December 4, 2019, 2,291* cases of hospitalized e-cigarette, or vaping, product use associated lung injury (EVALI) have been reported to CDC from 50 states, the District of Columbia, and 2 U.S. territories (Puerto Rico and U.S. Virgin Islands).
                        • Forty-eight deaths have been confirmed in 25 states and the District of Columbia (as of December 4, 2019):
                          • Alabama, California, Connecticut, Delaware, District of Columbia, Florida, Georgia, Illinois, Indiana, Kansas, Louisiana, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, New Jersey, New York, Oregon, Pennsylvania, Tennessee, Texas, Utah, and Virginia
                          • The median age of deceased patients was 52 years and ranged from 17 to 75 years (as of December 4, 2019).
                        • More deaths are under investigation.
                        • The EVALI cases and EVALI deaths reported as of December 4, 2019, include data from a two-week period, November 17th to November 30th.
                        • As of December 4, 2019, CDC will only report hospitalized EVALI cases and EVALI deaths regardless of hospitalization status. CDC has removed* nonhospitalized cases from previously reported cases counts.
                        • Among the 2,016 cases of e-cigarette, or vaping, product use associated lung injury (EVALI) reported to CDC with available data on hospitalization status (as of November 5, 2019):
                          • 95% were hospitalized, and 5% were not hospitalized.
                          • 68% were male (among 1,905 patients with data on sex)
                          • 77% were under 35 years old, with a median age of 24 years and age range from 13 to 78 years (among 1,906 patients with data on age)
                          • By age group category:
                            • 15% of patients were under 18 years old;
                            • 38% of patients were 18 to 24 years old;
                            • 24% of patients were 25 to 34 years old; and
                            • 23% of patients were 35 years or older.
                        • 1,184 patients had complete information** on substances used in e-cigarette, or vaping, products in the 3 months prior to symptom onset, of whom (as of November 5, 2019):
                          • 83% reported using THC-containing products; 35% reported exclusive use of THC-containing products.
                          • 61% reported using nicotine-containing products; 13% reported exclusive use of nicotine-containing products.
                          • 48% reported both THC- and nicotine-containing product use.
                          • 4% reported no THC- or nicotine-containing product use.

                        * Due to only reporting hospitalized EVALI cases as of December 4, 2019, CDC removed 175 nonhospitalized cases from previously reported national case counts.

                        ** Based on complete reports received.


                        Number of Lung Injury Cases Reported to CDC as of December 3, 2019




                        Dates of symptom onset and hospital admission for patients with lung injury associated with e-cigarette use, or vaping — United States, March 31–November 30, 2019

                        Top of Page

                        What CDC is Doing

                        Public Health Response:
                        • CDC’s Lung Injury response efforts are committed to:
                          • Identify and define the risk factors and the source for lung disease associated with e-cigarette product use, or vaping.
                          • Detect and track confirmed and probable cases in the US.
                          • Communicate actionable recommendations to state, local, and clinical audiences.
                          • Establish lab procedures that can assist with the public heath investigation and patient care.

                        Partnerships:
                        • CDC is working 24/7 to identify the cause or causes of this outbreak.
                        • CDC continues to work closely with FDA, states, public health partners, and clinicians on this investigation by providing consultation and technical assistance to states on communication, health alerts, public outreach, and surveillance.
                        • CDC has activated the Emergency Operations Center (EOC) to coordinate activities and provide assistance to states, public health partners and clinicians around the nation.
                        • CDC worked with states to create case definitions to classify confirmed and probable cases in a consistent way. States are in the process of classifying patients.
                          • CDC will report numbers of confirmed and probable lung injury cases once states have finalized their classification of cases.
                        • By invitation, CDC has deployed Epidemic Intelligence Service (EIS) officers and other CDC staff to support states.
                        • CDC has been communicating with international public health partners. Currently, there is a very small number of similar lung injuries outside the U.S. and not close to the magnitude in the U.S.

                        Media and Communication:
                        • CDC is maintaining an outbreak webpage with key messages and weekly updates on case counts, deaths, and resources available to healthcare providers, health departments, and the public.
                        • CDC is holding congressional briefings, media telebriefings, and regular calls with health departments, clinicians to provide timely updates.

                        Laboratory Testing:
                        • CDC is currently testing bronchoalveolar lavage (BAL) fluid samples as well as blood or urine samples paired to BAL fluid samples.
                        • CDC is testing pathologic specimens, including lung biopsy or autopsy specimens, associated with patients.
                        • CDC is offering aerosol emission testing of case-associated product samples from e-cigarette, or vaping, products, and e-liquids. For more information about submission, see Product Sample Submission Information.
                        • Results can help provide insight into the nature of chemical exposure(s) contributing to this outbreak.
                        • CDC developed guidance documents to assist public health laboratories, healthcare providers, pathologists, and others with specimen collection, storage, and submission to CDC for testing.
                        • For more information and resources visit For the Public, For Healthcare Providers and For State and Local Health Departments as well as our Publications and Resources page.
                        https://www.cdc.gov/tobacco/basic_in...ak-information
                        Twitter: @RonanKelly13
                        The views expressed are mine alone and do not represent the views of my employer or any other person or organization.

                        Comment


                        • #57
                          First vaping related death reported in South Carolina
                          Dec 7, 2019 12:23 AM EST abccolumbiasitestaff


                          COLUMBIA, SC (WOLO) – The South Carolina Department of Health and Environmental Control has reported the state’s first vaping related death.

                          Officials say the death came out of the upstate where someone 65 years or older, who already had health conditions, died.

                          The Centers for Disease Control and Prevention has identified vitamin e acetate as a possible common factor among e-cig users who have fallen ill.
                          ...
                          COLUMBIA, SC (WOLO) – The South Carolina Department of Health and Environmental Control has reported the state’s first vaping related death. Officials say the death came out of the upstate where someone 65 years or older, who already had health conditions, died. The Centers for Disease Control and Prevention has identified vitamin e acetate as a possible common factor among...
                          Twitter: @RonanKelly13
                          The views expressed are mine alone and do not represent the views of my employer or any other person or organization.

                          Comment


                          • #58
                            Second vaping-related death reported in Florida
                            THE ASSOCIATED PRESS
                            DECEMBER 11, 2019 08:46 AM
                            TALLAHASSEE, FLA.
                            The Florida Department of Health says a second person in Florida has died due to complications from vaping.

                            The Orlando Sentinel reported Wednesday that the department also reported a slight increase in the number of vaping-associated illnesses, which rose from 99 to 103 cases.
                            ...
                            Twitter: @RonanKelly13
                            The views expressed are mine alone and do not represent the views of my employer or any other person or organization.

                            Comment


                            • #59
                              Updated December 12, 2019, at 1:00 PM EST

                              What is New
                              CDC has analyzed national data on use of THC-containing product brands by e-cigarette, or vaping, product use-associated lung injury (EVALI) patients.
                              Overall, 152 different THC-containing product brands were reported by EVALI patients.
                              Dank Vapes, a class of largely counterfeit THC-containing products of unknown origin, was the most commonly reported product brand used by patients nationwide, although there are regional differences. While Dank Vapes was most commonly reported in the Northeast and South, TKO and Smart Cart brands were more commonly reported by patients in the West and Rove was more common in the Midwest.
                              The data further supports that EVALI is associated with THC-containing products and that it is not likely associated with a single THC-containing product brand.
                              CDC and FDA recommend that people should not use THC-containing e-cigarette, or vaping, products, particularly from informal sources like friends, family, or in-person or online sellers.
                              Vitamin E acetate should not be added to e-cigarette, or vaping, products. Additionally, people should not add any other substances not intended by the manufacturer to products, including products purchased through retail establishments.
                              CDC, FDA, and state health authorities have made progress in identifying substances of concern in EVALI. However, there are many different substances and product sources that remain under investigation, and there may be more than one cause.
                              The latest national and state data from patient reports and product sample testing suggest THC-containing e-cigarette, or vaping, products, particularly from informal sources like friends, family, or in-person or online sellers, are linked to most of the cases and play a major role in the outbreak.
                              While it appears that vitamin E acetate is associated with EVALI, there are many different substances and product sources that are being investigated, and there may be more than one cause.
                              Therefore, the best way for people to ensure that they are not at risk while the investigation continues is to consider refraining from the use of all e-cigarette, or vaping, products.CDC will continue to update guidance, as appropriate, as new data become available from this complex outbreak.
                              CDC will continue to update guidance, as appropriate, as new data emerges from this complex outbreak.
                              ,,,



                              Latest Outbreak Information
                              • This complex investigation spans almost all states, involves over 2,400 patients, and a wide variety of brands and substances and e-cigarette, or vaping, products.
                              • As of December 3, 2019, CDC is only reporting hospitalized EVALI cases and EVALI deaths regardless of hospitalization status. CDC has removed nonhospitalized cases from previously reported case counts. See Public Health Reporting for more information.
                              • As of December 10, 2019, a total of 2,409 cases of hospitalized e-cigarette, or vaping, product use-associated lung injury (EVALI) have been reported to CDC from 50 states, the District of Columbia, and two U.S. territories (Puerto Rico and U.S. Virgin Islands).
                              • Fifty-two deaths have been confirmed in 26 states and the District of Columbia (as of December 10, 2019):
                                • Alabama, California, Connecticut, Delaware, District of Columbia, Florida, Georgia, Illinois, Indiana, Kansas, Louisiana, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, New Jersey, New York, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, and Virginia
                                • The median age of deceased patients was 52 years and ranged from 17 through 75 years (as of December 10, 2019).
                                • More deaths are currently under investigation.
                              • Data suggest the outbreak might have peaked in mid-September. However, states continue to report new cases, including deaths, to CDC on a weekly basis.
                              • Among cases of hospitalized EVALI patients reported to CDC with available data (as of December 3, 2019):
                                • 67% were male (among 2,155 patients with data on sex)
                                • 78% were under 35 years old, with a median age of 24 years and age range from 13 to 77 years (among 2,159 patients with data on age)
                                • By age group category:
                                  • 16% of patients were under 18 years old;
                                  • 38% of patients were 18 to 24 years old;
                                  • 24% of patients were 25 to 34 years old; and
                                  • 23% of patients were 35 years or older.
                              • 1,782 hospitalized patients had complete information* on substances used in e-cigarette, or vaping, products in the 3 months prior to symptom onset, of whom (as of December 3, 2019):
                                • 80% reported using THC-containing products; 35% reported exclusive use of THC-containing products.
                                • 54% reported using nicotine-containing products; 13% reported exclusive use of nicotine-containing products.
                                • 12% reported using cannabidiol (CBD)-containing products; 1% reported exclusive use of cannabidiol (CBD)-containing products.
                                • 40% reported both THC- and nicotine-containing product use.
                                • 5% reported no THC-, nicotine-, or CBD-containing product use.
                              • Among hospitalized EVALI patients who reported using THC-containing e-cigarette, or vaping product brands:
                                • The most commonly reported product brand included Dank vapes (56%), followed by TKO (15%), Smart Cart (13%), and Rove (12%). However, regional differences in THC-containing product use were noted.

                              * Based on complete reports received.
                              ...
                              https://www.cdc.gov/tobacco/basic_in...ak-information
                              Twitter: @RonanKelly13
                              The views expressed are mine alone and do not represent the views of my employer or any other person or organization.

                              Comment


                              • #60
                                Latest Outbreak Information
                                • This complex investigation spans all states, involves over 2,500 patients, and a wide variety of brands and substances and e-cigarette, or vaping, products.
                                • As of December 3, 2019, CDC is only reporting hospitalized EVALI cases and EVALI deaths regardless of hospitalization status. CDC has removed nonhospitalized cases from previously reported case counts. See Public Health Reporting for more information.
                                • As of December 17, 2019, a total of 2,506 cases of hospitalized e-cigarette, or vaping, product use-associated lung injury (EVALI) have been reported to CDC from 50 states, the District of Columbia, and two U.S. territories (Puerto Rico and U.S. Virgin Islands).
                                • Fifty-four deaths have been confirmed in 27 states and the District of Columbia (as of December 17, 2019):
                                  • Alabama, California, Connecticut, Delaware, District of Columbia, Florida, Georgia, Illinois, Indiana, Kansas, Louisiana, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, New Jersey, New York, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Utah, and Virginia
                                  • The median age of deceased patients was 52 years and ranged from 17 through 75 years (as of December 17, 2019).
                                  • More deaths are currently under investigation.
                                • Data suggest the outbreak might have peaked in mid-September. However, states continue to report new cases, including deaths, to CDC on a weekly basis.
                                • Among cases of hospitalized EVALI patients reported to CDC with available data (as of December 3, 2019):
                                  • 67% were male (among 2,155 patients with data on sex)
                                  • 78% were under 35 years old, with a median age of 24 years and age range from 13 to 77 years (among 2,159 patients with data on age)
                                  • By age group category:
                                    • 16% of patients were under 18 years old;
                                    • 38% of patients were 18 to 24 years old;
                                    • 24% of patients were 25 to 34 years old; and
                                    • 23% of patients were 35 years or older.
                                • 1,782 hospitalized patients had complete information* on substances used in e-cigarette, or vaping, products in the 3 months prior to symptom onset, of whom (as of December 3, 2019):
                                  • 80% reported using THC-containing products; 35% reported exclusive use of THC-containing products.
                                  • 54% reported using nicotine-containing products; 13% reported exclusive use of nicotine-containing products.
                                  • 12% reported using cannabidiol (CBD)-containing products; 1% reported exclusive use of cannabidiol (CBD)-containing products.
                                  • 40% reported both THC- and nicotine-containing product use.
                                  • 5% reported no THC-, nicotine-, or CBD-containing product use.
                                • Among hospitalized EVALI patients who reported using THC-containing e-cigarette, or vaping product brands:
                                  • The most commonly reported product brand included Dank vapes (56%), followed by TKO (15%), Smart Cart (13%), and Rove (12%). However, regional differences in THC-containing product use were noted.

                                * Based on complete reports received.
                                ...
                                Twitter: @RonanKelly13
                                The views expressed are mine alone and do not represent the views of my employer or any other person or organization.

                                Comment

                                Working...
                                X